ClinicalTrials.Veeva

Menu

Safety and Effectiveness of the External Fastening System for Temporary Active Fixation Pacemakers (TEMPACE)

I

ICU Medical Technologies

Status

Completed

Conditions

Bradycardia
Arrythmia

Treatments

Device: KronoSafe® System

Study type

Interventional

Funder types

Other
Industry

Identifiers

NCT05351658
TEMPACE

Details and patient eligibility

About

Temporary cardiac pacing with active-fixation leads (TPAFL) using a reusable permanent pacemaker generator has been shown to be safer than lead systems without fixation. However, TPAFL requires the off-label (non-certificated) use of Pacemaker leads and generators. It is designed a fastening system to ensure the safety and efficacy of the procedure: the KronoSafe System®. The aim of this study is to demonstrate the safety and effectiveness of the KronoSafe System® for temporary pacing in a series of patients receiving TPAFL.

Enrollment

30 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patient older than 18 years.
  • Need for temporary cardiac stimulation
  • Temporary active fixation pacemaker implantation through left or right jugular access.
  • Signature of informed consent
  • Correct functioning of the electrode after the implantation: sensing of the R wave above 5 millivolts. Ventricular pacing threshold below 1 volt. Electrode impedance between 400-1200 Ohm.
  • Pacemaker programming with stimulation output at 5 volts intensity and 1 millisecond pulse duration.
  • Placement of the KronoSafe® fastening system after electrode implantation.

Exclusion criteria

  • Complication during the procedure: pneumothorax, hematoma at the puncture site, cardiac perforation, accidental arterial puncture or other that, in the investigator's opinion, poses an added risk of pacemaker dysfunction.
  • Need to transfer the patient to another center with loss of follow-up.
  • Absence of surveillance through continuous electrocardiographic monitoring with detection of arrhythmic events.

Trial design

Primary purpose

Supportive Care

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

30 participants in 1 patient group

Temporary Cardiac Pacing with Active-Fixation Leads
Experimental group
Treatment:
Device: KronoSafe® System

Trial contacts and locations

2

Loading...

Central trial contact

Raimundo Vicente, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems